SYNTHETIC LETHALITY IN P53 MUTATED B-CELL MALIGNANCIES: CHK-1 INHIBITION AND DNA-PK INHIBITION EFFECT IN CELL LINES AND PRIMARY CLL CELLS

被引：0
|
作者：
Zemanova, J. [1 ]
Sebejova, L. [1 ]
Paruch, K. [2 ]
Hylse, O. [2 ]
Pospisilova, S. [1 ]
Mayer, J. [3 ]
Trbusek, M. [1 ]
机构：
[1] FN St Anna, Cent European Inst Technol MU, Brno, Czech Republic
[2] FN St Anna, Int Clin Res Ctr, Brno, Czech Republic
[3] FN Brno, Dept Internal Med, Brno, Czech Republic
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P971
引用
收藏
页码：402 / 402
页数：1
相关论文
共 50 条
  • [1] Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status
    Hafsi, Hind
    Dillon, Magnus T.
    Barker, Holly E.
    Kyula, Joan N.
    Schick, Ulrike
    Paget, James T.
    Smith, Henry G.
    Pedersen, Malin
    McLaughlin, Martin
    Harrington, Kevin J.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [2] Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin
    Alikarami, Fatemeh
    Safa, Majid
    Faranoush, Mohammad
    Hayat, Parisa
    Kazemi, Ahmad
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 94 : 1077 - 1093
  • [3] Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells
    Origanti, S.
    Cai, S-R
    Munir, A. Z.
    White, L. S.
    Piwnica-Worms, H.
    ONCOGENE, 2013, 32 (05) : 577 - 588
  • [4] Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells
    S Origanti
    S-r Cai
    A Z Munir
    L S White
    H Piwnica-Worms
    Oncogene, 2013, 32 : 577 - 588
  • [5] Pharmacological DNA-PK inhibition induces ATM/p53 dependent premature senescence with immunomodulatory phenotype in irradiated cancer cells
    Guo, Yige
    Sun, Qing
    Liu, Xiaohong
    Puc, Janusz
    Czauderna, Frank
    Zenke, Frank
    Blaukat, Andree
    Vassilev, Lyubomir T.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Defective expression of ataxia telangiectasia mutated (ATM) as a cause of p53 dysfunction in B-cell chronic lymphocytic leukemia (CLL).
    Pettitt, AR
    Stankovic, T
    Sherrington, PD
    Stewart, GS
    Cawley, JC
    Taylor, AM
    BLOOD, 1999, 94 (10) : 490A - 490A
  • [7] Chk1 Inhibition Enhances Cisplatin Cytotoxicity Regardless of p53 Status in Human Small Cell Lung Cancer Cells
    Hsu, Wei-Hsun
    Hsu, Shuo-Tse
    Rao, Guanhua
    Kim, In-Gyu
    Alberobello, Anna T.
    Wang, Yisong
    Giaccone, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S399 - S399
  • [8] p53-dependent treatment response to DNA-PK inhibition in combination with irradiation in head and neck squamous cell carcinoma (HNSCC) models
    Hayrapetyan, Liana
    Roth, Selina M.
    Hovhannisyan, Lusine
    Medo, Matus
    Aebersold, Daniel M.
    Zimmer, Yitzhak
    Medova, Michaela
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Relationship of ionizing radiation-induced synthetic lethality of PARP inhibition in BRCA1-proficient cancer cells with p53
    Sizemore, Steven T.
    Mohammad, Rahman
    Sizemore, Gina M.
    Yu, Hao
    Ostrowski, Michael C.
    Chakravarti, Arnab
    Xia, Fen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells
    Kalli Koniaras
    Andrew R Cuddihy
    Helen Christopoulos
    Annette Hogg
    Matthew J O'Connell
    Oncogene, 2001, 20 : 7453 - 7463
12345